United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 8,750 United Therapeutics Corporation shares (Form 4)

Traded Jun 22, 2026 · Filed Jun 23, 2026

On Jun 22, 2026, Edgemond James (CFO AND TREASURER) sold 8,750 United Therapeutics Corporation shares at an average US$538.15 for US$4.71M under a trading plan, leaving 18,876 shares. Filed Jun 23, 2026 (Form 4).

Sold
8,750 shares
Price
US$538.15 average (US$534.06 to US$541.25)
Value
US$4.71M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common StockOption exercise8,750US$146.0327,626Direct
Jun 22, 2026Common StockSale164US$534.0627,462Direct
Jun 22, 2026Common StockSale865US$534.9826,597Direct
Jun 22, 2026Common StockSale1,091US$536.0525,506Direct
Jun 22, 2026Common StockSale840US$537.1824,666Direct
Jun 22, 2026Common StockSale2,266US$538.2322,400Direct
Jun 22, 2026Common StockSale1,994US$539.1320,406Direct
Jun 22, 2026Common StockSale280US$539.8320,126Direct
Jun 22, 2026Common StockSale1,250US$541.2518,876Direct

Source

View original at SEC

Related